Evaluation of serum interleukin-17 A and interleukin-22 levels in pediatric patients with autism spectrum disorder: a pilot study.
Dina E SallamYoustina S ShakerGehan A MostafaReham M El-HossinySara Ibrahim Abd El Fattah TahaMostafa Abd Elazeem Hassan AhamedPublished in: BMC pediatrics (2024)
Raised serum levels of IL-17 A and IL-22 are associated with ASD; only IL-22, not IL-17 A, is correlated with ASD severity. This finding proposes IL-22 as a possible future effective target for ASD treatment. To fully comprehend the significance of these cytokines in ASD and their possible effects on ASD diagnosis and treatment, more research on a wider scale is required.